CLINICAL_TRIALS
trial_result
· 2019-06-14
Clinical Trial Update: A Bioavailability Study of LY2452473 and Tadalafil [Phase 1]
Summary
Phase 1 bioavailability study of LY2452473 and tadalafil completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Erectile Dysfunction | Phase 1 | Status: COMPLETED | Results posted: 2019-06-14